Wellysis

Wellysis develops a smart wearable wristband and companion application for continuous ECG monitoring, enabling users to verify live-streaming electrocardiogram data on their mobile devices in real time. The platform automatically transfers ECG reports to a cloud-based system for AI-assisted analysis and interpretation, allowing cardiologists to remotely diagnose heart rhythm abnormalities and cardiac conditions. The wearable device provides medical-grade cardiac monitoring in a consumer-friendly form factor, supporting continuous heart health tracking for patients with cardiac and vascular disorders. Wellysis's technology combines wearable biosensing hardware with cloud-based AI analysis and physician review workflows, creating an end-to-end cardiac monitoring solution for healthcare providers and patients. Founded in 2019 and headquartered in Seoul, South Korea, the company has raised approximately $4M in Series A funding. Wellysis differentiates itself through its integrated approach combining wearable ECG hardware, mobile live-streaming, cloud AI analysis, and cardiologist review, delivering remote cardiac monitoring for value-based care and chronic disease management.